Anti Allergy
NDC 54738-103, Chlorpheniramine Maleate, tablet, from Richmond Pharmaceuticals, Inc..
- Product NDC
- 54738-103
- Status
- Listed
- Labeler
- Richmond Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- part341
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54738-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORPHENIRAMINE MALEATE4 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54738-103-01 | 54738010301 | 100 TABLET in 1 BOTTLE (54738-103-01) |
| 54738-103-03 | 54738010303 | 1000 TABLET in 1 BOTTLE (54738-103-03) |
| 54738-103-14 | 54738010314 | 24 TABLET in 1 BOTTLE (54738-103-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54738-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54738-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54738-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.